Global Gel Stents Market

Pages : 185 | Category: | Publishers: Goldstein Research


Global Gel Stent Market
Market Overview
Glaucoma is the second cause of blindness after cataract, with 3 million Americans suffering from it. The global glaucoma market estimated to be USD 5 billion in 2016. Vision impairment or blindness hit the individuals when fluids are building up in the eye resulting in pressurizing the optic nerve and relieving this strain has been a challenge for ophthalmologists. In 2016, after the approval of XEN45 gel stent which is collagen-derived gelatin tube, Dr. Cristobal Cruz-Colon was the first ophthalmologist to successfully implant the XEN GEL stent at Coral Gables Surgery Center.
Allergan receives FDA clearance for the XEN Gel Stent, a new surgical treatment for refractory glaucoma and will provide the new treatment option to bring down the intraocular pressure of the struggling patients. Over 10,500 stents were distributed worldwide in 2016.
Although in Philippines is developing more substantive requirements for medical devices but specific devices like abutment, stents, injection port, abdominal pad, anesthesia set, alcohol swab, surgical blade, etc are subjected to mandatory registration.
Market Segmentation
• By Clinical Trials
o Preclinical
o Clinical phase I/II
o Clinical Phase II
o Clinical Phase III
o Research
• By End User
o Eye Clinics
o Eye Research Institutes
o Hospitals
• By Geography
o North America (US, Canada) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Rest of the World {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Market Size Outlook (2016-2024)
The global gel stent market projected to garner USD 17.25 billion by 2024. The global gel stent market tends to reach USD 0.37 billion by 2024 at a CAGR of 30% over the forecast period. Major portion of global gel stent market contributes to research (40%) in clinical trials segment and eye research institutes (55%) in end user segment.
In terms of value, North America and Europe is expected to dominate the global gel stents market by acquiring more than 50% market share, owing to the increasing glaucoma cases with increasing geriatric population. APAC gel stents market is expected to project the highest growth rate due to rising interest in advanced and novel technology.
Growth Drivers & Challenges
The Allergan gel stent is soft which involve minimal invasive procedure, 6mm long with width of human hair approximately and permanent implant setup are the driving factors for global gel stent market. Gel stents are the breakthrough for the patients with primary open glaucoma and failed surgical treatment i.e. unresponsive to traditional medical therapy.
Main restraint in global gel stent market is that only few qualified ophthalmologist can determine if implant is suitable for patient’s condition. Product portfolio for gel stents is not big enough like other stents, mandatory registrations for medical devices and non commercialized insurance coverage for this product hinders the global gel stent market.
Key Market Players
o Synopsis
o Business Strategy
o Product Portfolio
o SWOT Analysis
• AqueSys Inc.
• Glaukos
• Innfocus
Scope Background
Market Synopsis
Market Segmentation
The Global Gel Stent Market is segmented as follows:
• By Clinical Trials (Market Size, Demand Analysis and Growth Analysis)
• By End-User (Market Size, Demand Analysis and Growth Analysis)
By Regions
• North America (U.S., Canada) {Market Size, Growth Analysis and Opportunity Analysis}
• Latin America (Argentina, Mexico, Brazil and Rest of Latin America) {Market Size, Growth Analysis and Opportunity Analysis}
• Europe (Germany, Italy, Spain, France, The U.K., Netherlands, Sweden, Hungary, Russia, Poland, Rest of Europe) {Market Size, Growth Analysis and Opportunity Analysis}
• Asia-Pacific (China, India, Singapore, Japan, Hong-Kong, Australia, New Zealand, South Korea and Rest of Asia Pacific) {Market Size, Growth Analysis and Opportunity Analysis}
• Middle East and North Africa (MENA) {Market Size, Growth Analysis and Opportunity Analysis}
• Rest of World {Market Size, Growth Analysis and Opportunity Analysis}
Market Dynamics: Growth Drivers, Restraints and Opportunities
• Risk Factors
• Regional Variations
• Recent Trends and Developments
Key Market Players
• Synopsis
• Business Strategy
• Product Portfolio
• SWOT Analysis
Porter’s Five Force Model
Market Landscape: Competition and Beyond
Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem
Expert Analysis
Concluding Remarks

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements